Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports.Check Now!

Hero Background

covid 19

Know how Pharma industry is trying to free the whole world from the clutches of novel human coronavirus SARS-CoV-2

COVID-19

Over the last months, the world has faced one of the most unexpected challenges in the form of a novel coronavirus, SARS-CoV-2, infection.

Through the whitepaper, DelveInsight aims to make its clients and users aware of the exact scenario of the novel coronavirus SARS-CoV-2 and the disease COVID-19. In severe cases, the infection can cause pneumonia, acute respiratory distress syndrome (ARDS), multi-organ failure, or death. The virus primarily spreads through respiratory droplets, airborne particles, and contaminated surfaces.

The whitepaper is a detailed description of SARS-CoV-2 virus, its morphology and pathophysiology, and the trends of the patients affected, most prevalent symptoms, as well as understand the asymptomatic traits. It also covers a comparative analysis of the three human coronaviruses, namely SARS, MERS and SARS-CoV-2, along with a detailed timeline of the spread of the novel coronavirus from ground zero.

COVID-19 marked a pivotal chapter in modern history. While much progress has been made in controlling the disease, ongoing vigilance, scientific innovation, and international collaboration remain critical to managing current and future public health threats.


It highlights the transmission of the virus from Ground Zero to all over the world, with enriched graphical analysis of the worst-hit countries with the rate of the spread. An exclusive feature includes a detailed analysis of the ongoing clinical trials of the drugs and vaccines in the developmental pipeline.

Know More About Whats Covered:

  • Coronavirus Family
  • Past Coronavirus Infections
  • Novel SARS-CoV-2 Infection Characteristics
  • Timeline of Spread
  • Top Countries Affected
  • Clinical Trial Scenario
  • Pipeline Products

More Newsletter Whitepaper